Drug Trial Radar · NCT02000089
The Cancer of the Pancreas Screening-5 CAPS5)Study
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
9,000
Planned (sponsor's estimate)
Start
Jan 6, 2014
Primary completion
Dec 2028
Study completion Jun 2029
Sponsor
- Lead sponsor
- Johns Hopkins UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI); National Institutes of Health (NIH); American Association for Cancer Research
- First posted
- Dec 3, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Conditions
- Pancreas Cancer
- Peutz-Jeghers Syndrome (PJS)
- Gene Mutation
- Germline Mutation Carrier
- Lynch Syndrome
Interventions
SecretinDrug
inject Secretin to stimulate pancreatic digestive fluid, which is collected in duodenum near ampulla via endoscope suction port. This fluid will be assessed for biomarkers.
MRIDiagnostic test
MRI abdomen with contrast (MRCP) will be clinically indicated for abnormal novel CA-19-9 lab results.
Tumor marker gene test with CA19-9Other
A tumor marker gene test that will be used to stratify individuals into one of several circulating tumor marker reference ranges for CA19-9. The variants in the genes FUT3 and FUT2 affect the levels of CA19-9.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate pancreatic juice for early cancer markers.Time frame: 10 years
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Yale University
New Haven, Connecticut · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Dana Farber Cancer Center, Harvard University
Boston, Massachusetts · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
NYU Langone Medical Center
New York, New York · Recruiting
Columbia University Medical Center
New York, New York · Recruiting
Case Comprehensive Cancer Center, Case Western Medical Reserve
Cleveland, Ohio · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
University of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.